HIGH POINT, N.C.--(BUSINESS WIRE)--Bien-Etre Labs, LLC, a nutraceutical development company designing pre- and probiotic supplements to regulate the human biome, as well as researching novel approaches to healthy ageing and longevity, announces the appointment of Mr. Steve P. Prescott to the position of President of the company.
Steve’s impeccable stewardship assisted DuPont through the successful launch of over 100 new products between 2013 and 2017, and since May of 2017, he has demonstrated strong leadership in both mature and spin off start-up companies in the probiotic field. “Steve brings over 20 years of executive level business experience to drive product line strategies, while his background in bio-chemistry and natural product synthesis, will springboard the company’s business plan to bring best-in-class products to the world stage,” says company Founder and PhD., Adnan M. Mjalli.
Dr. Mjalli has patented hundreds of pharmaceuticals and formulations beneficial to the human condition. A focus of the Bien-Etre Labs product line is to promote healthy ageing and longevity by introducing 100% natural, proprietary products to repair imbalances in the human biome, where Mjalli believes, through his 30 years of research and drug development, “lies one of the most important opportunities to naturally enhance the body’s ability to protect itself from pathogens.”
Steve says he feels truly fortunate to join the company’s “incredible team of scientists and professionals whose overriding goal is to support health and well-being, as the French words ‘Bien-Etre’ describes. I cannot imagine a better platform to pursue my life’s work than at Bien-Etre Labs where my background and experience in pharmaceutical and nutraceutical development, product manufacturing, and commercial strategy optimization come together to meet this exciting company’s potential.”
Bien-Etre Labs, LLC was founded by Dr. Mjalli in 2014 and is incorporated in Delaware and North Carolina, where it operates one of its labs in High Point. During the Fall of 2018 and into 2019, the company began a round of investor funding and is well positioned to advance to market.